Table 2 Effect of pyridine derivatives on the H2S-synthesizing activity of tCBS, CSE and MST.

From: Screening Pyridine Derivatives against Human Hydrogen Sulfide-synthesizing Enzymes by Orthogonal Methods

 

tCBS

CSE

MST

H2S production (%) (Z’ factor: 0.60)

CV

Z-score

H2S production (%) (Z’ factor: 0.78)

CV

Z-score

H2S production (%) (Z’ factor: 0.51)

CV

Z-score

Control

100.0 (N = 18)

11.6

100.0 (N = 9)

12.0

100.0 (N = 9)

6.8

 

Blank

5.4 (N = 18)

37.2

8.2

5.2 (N = 9)

27.5

7.9

16.9 (N = 9)

48.5

12.1

AOAA

8.8

12.1

7.9

6.7

59.7

7.8

C1*

98.4

3.4

0.1

102.3

2.8

−0.2

103.0

7.8

−0.4

C2

92.4

4.2

0.7

98.4

2.7

0.1

102.5

0.5

−0.4

C3

89.5

5.7

0.9

96.7

2.5

0.3

103.9

5.3

−0.6

C4

77.4

8.2

2.0

101.0

3.0

−0.1

100.0

4.1

0.0

C5

93.5

7.9

0.6

122.0

0.0

−1.8

107.5

0.6

−1.1

C6*

79.8

6.6

1.7

92.6

0.9

0.6

99.7

4.0

0.0

C7

95.1

2.1

0.4

97.3

1.8

0.2

99.9

6.8

0.0

C8

92.4

9.8

0.7

94.0

1.4

0.5

87.4

7.5

1.8

C9

97.1

1.7

0.2

90.3

3.6

0.8

96.5

3.4

0.5

C10

103.8

11.9

−0.3

98.0

1.0

0.2

98.0

3.7

0.3

C11

108.6

7.3

−0.7

106.9

8.4

−0.6

89.6

0.5

1.5

C12*

97.0

16.7

0.3

90.8

5.4

0.8

103.6

4.0

−0.5

C13

97.9

8.7

0.2

89.8

2.4

0.9

93.1

3.7

1.0

C14

85.0

2.8

1.3

93.0

6.5

0.6

106.3

7.4

−0.9

C15

80.7

1.1

1.7

92.6

2.4

0.6

91.2

2.1

1.3

C16

122.5

1.7

−2.0

93.8

15.3

0.5

104.8

7.9

−0.7

C17

109.2

3.9

−0.8

97.2

7.6

0.2

102.3

3.9

−0.3

C18

105.2

13.2

−0.5

94.4

2.3

0.5

101.9

2.1

−0.3

C19

118.4

3.2

−1.6

96.6

4.4

0.3

103.9

6.6

−0.6

C20*

101.5

1.3

−0.1

116.2

18.8

−1.4

103.4

9.0

−0.5

C21*

79.0

7.6

1.8

101.0

1.0

−0.1

103.3

3.1

−0.5

C22

68.3

4.2

2.7

100.6

8.2

−0.1

107.7

1.8

−1.1

C23

115.8

8.7

−1.4

91.3

3.3

0.7

103.4

2.0

−0.5

C24*

94.7

5.5

0.5

112.2

1.6

−1.0

101.6

3.6

−0.2

C25

94.7

14.1

0.5

102.9

21.7

−0.2

106.6

3.5

−1.0

C26

97.5

23.2

0.2

99.8

1.5

0.0

97.2

4.0

0.4

C27

104.8

4.9

−0.4

96.2

3.6

0.3

98.8

1.3

0.2

C28

93.8

16.7

0.5

91.8

14.0

0.7

108.0

2.7

−1.2

C29

81.3

22.5

1.6

97.4

5.3

0.2

107.6

6.4

−1.1

C30

50.3

12.9

4.3

64.2

9.7

3.0

130.3

2.3

−4.4

C31*

60.7

24.6

3.4

38.4

5.1

5.1

119.1

6.8

−2.8

  1. *Compounds tested at a final concentration of 500 µM rather than 1 mM.